INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
Funding Amount
$3,000,000 total
Deadline
June 15, 2028
625 days left
Number of Awards
4
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- For-profit businesses
- Nonprofits (501(c)(3))
- City & township governments
- School districts
- Public & Indian housing authorities
- County governments
- Small businesses
- Private colleges & universities
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Overview
The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this NOFO may not exceed five years. This NOFO provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33) of up to three years, although the total duration of the award may not exceed five years. This NOFO requires measurable R61 milestones.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: RFA-OD-25-021
- Total Funding: $3,000,000
- Expected Awards: 4
- Instrument: grant
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Developmental disabilities
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,745,000 total
Deadline
September 30, 2026
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $3,300,000
Deadline
September 30, 2026
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,000,000 total
Deadline
September 30, 2026
Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$2,000,000 total
Deadline
September 30, 2026
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
National Institutes of Health
Amount
Up to $500,000
Deadline
October 1, 2026
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
National Institutes of Health
Amount
Up to $700K
Deadline
October 1, 2026
Ready to apply for INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required). Now let's win it.